Broad antibacterial spectrum, high oral bioavailability and excellent tissue penetration
combined with safety and few, yet rare, unwanted effects, have made the quinolones class of …

The world was unprepared for coronavirus disease 2019 (COVID-19) and remains ill-
equipped for future pandemics. While unprecedented strides have been made developing …

Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) infects cells
through interaction of its spike protein (SARS2-S) with angiotensin-converting enzyme 2 …

The acid sphingomyelinase/ceramide system has been shown to be important for cellular
infection with at least some viruses, for instance, rhinovirus or severe acute respiratory …

Abstract Background/Aim SARS‐CoV‐2 is one of the coronavirus families that emerged at
the end of 2019. It infected the respiratory system and caused a pandemic worldwide …

Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative
agent of coronavirus disease 2019 (COVID-19), enters the host cells through two main …

Ciprofloxacin is a widely used antibiotic in the fluoroquinolone class. It is widely
acknowledged by various researchers worldwide, and it has been documented to have a …

To further exploit the new materials, a set of new salts containing ambroxol and hydroxyl
aromatic carboxylate moieties, namely,[H AXE]+ B–(B= MSA (1), 23A (2) and 26A (3))[AXE …

Ambroxol (Ax) is used as a mucolytics in the treatment of respiratory tract infections. Ax, at a
general dose for humans, does not alter Chlamydia pneumoniae growth in mice. Therefore …

В статье рассмотрены основные, а также малоизученные эффекты амброксола-
мукоактивного препарата, широко используемого в качестве мукокинетика и …